-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VqNHUHs2X37LF6G484IxX0KafR1SgljSYVhm5jRyI/ydoWeYWpZ96AK/LglFFjfP BGptFy7C3DehWnf69xPKFQ== 0000929624-98-000188.txt : 19980210 0000929624-98-000188.hdr.sgml : 19980210 ACCESSION NUMBER: 0000929624-98-000188 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980209 SROS: NASD GROUP MEMBERS: BA VENTURE PARTNERS II GROUP MEMBERS: BANK OF AMERICA NT&SA GROUP MEMBERS: BANKAMERICA CORP GROUP MEMBERS: BANKAMERICA CORPORATION GROUP MEMBERS: BANKAMERICA VENTURES SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CV THERAPEUTICS INC CENTRAL INDEX KEY: 0000921506 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 431570294 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-47551 FILM NUMBER: 98525883 BUSINESS ADDRESS: STREET 1: 3172 PORTER DR CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 6508120585 MAIL ADDRESS: STREET 1: 3172 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94304 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BANKAMERICA CORP CENTRAL INDEX KEY: 0000009672 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] IRS NUMBER: 941681731 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: BANK OF AMERICA CTR STREET 2: 555 CALIFORNIA ST CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 4156223530 MAIL ADDRESS: STREET 1: 555 CALIFORNIA STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94104 SC 13G/A 1 SCHEDULE 13G AMENDMENT NO. 1 ------------------------------ OMB APPROVAL ------------------------------ ------------------------------ OMB Number: 3235-0145 Expires: December 31, 1997 Estimated average burden hours per response . . . 14.90 ------------------------------ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* CV Therapeutics, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 126667104 ------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement [_]. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - ---------------------------- CUSIP No. 126667104 13G - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON BankAmerica Corporation - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER -0- NUMBER OF SHARES --------------------------------------------------------- 6 SHARED VOTING POWER BENEFICIALLY OWNED 380,998 BY EACH REPORTING --------------------------------------------------------- 7 SOLE DISPOSITIVE POWER PERSON WITH -0- --------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 304,686 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 380,998 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 4.5% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* HC - -------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Page 2 - ---------------------------- CUSIP No. 126667104 13G - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: Bank of America NT&SA - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER -0- NUMBER OF SHARES --------------------------------------------------------- 6 SHARED VOTING POWER BENEFICIALLY OWNED 380,998 BY EACH REPORTING --------------------------------------------------------- 7 SOLE DISPOSITIVE POWER PERSON WITH -0- --------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 304,686 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 380,998 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 4.5% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* BK - -------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Page 3 - ---------------------------- CUSIP No. 126667104 13G - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: BankAmerica Ventures - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION California - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER -0- NUMBER OF SHARES --------------------------------------------------------- 6 SHARED VOTING POWER BENEFICIALLY OWNED 304,686 BY EACH REPORTING --------------------------------------------------------- 7 SOLE DISPOSITIVE POWER PERSON WITH -0- --------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 304,686 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 304,686 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 3.6% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* CO - -------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Page 4 - ---------------------------- CUSIP No. 126667104 13G - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: BA Venture Partners II - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER -0- NUMBER OF SHARES --------------------------------------------------------- 6 SHARED VOTING POWER BENEFICIALLY OWNED 30,468 BY EACH REPORTING --------------------------------------------------------- 7 SOLE DISPOSITIVE POWER PERSON WITH -0- --------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 30,468 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 30,468 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 .4% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Page 5 Item 1 (a) Name of Issuer: CV Therapeutics, Inc. (b) Address of Issuer's 3172 Porter Drive Principal Executive Palo Alto, CA 94304 Offices: Item 2 (a) Names of Person Filing: BankAmerica Corporation ("BAC") Bank of America NT&SA ("BANTSA") BankAmerica Ventures ("BAV") BA Venture Partners II ("BAVPII") (b) Address of Principal (For BAC and BANTSA) Business Offices: 555 California Street San Francisco, CA 94104 (For BAV and BAVPII) 950 Tower Lane, Suite 700 Foster City, CA 94404 (c) Citizenship: BAC is organized under the laws of Delaware. BANTSA is a national banking association organized under the laws of the United States. BAV is organized under the laws of California. BAVPII is organized under the laws of Delaware. (d) Title of Class of Common Stock Securities: (e) CUSIP Number: 126667104 Item 3 If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b), check whether the person filing is a*: (a) [_] Broker or Dealer registered under Section 15 of the Act - ---------------- * This filing is being made primarily under Rule 13d-1(c) reporting BAV's and BAVPII's beneficial ownership. As to shares acquired by BANTSA, this filing is also being made pursuant to Rules 13d-1(b) and 13d-2(b). Page 6 (b) [X] Bank as defined in Section 3(a)(6) of the Act (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (d) [ ] Investment Company registered under Section 8 of the Investment Company Act (e) [ ] Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 (f) [ ] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see ss.240.13d-1(b)(1)(ii)(F) (g) [X] Parent Holding Company, in accordance with ss.240.13d-1(b)(ii)(G) (Note: See Item 7) (h) [ ] Group, in accordance with ss.240.13d-1(b)(1)(ii)(H)
Item 4 Ownership** (a) Amount Beneficially Owned: BAC 380,998 BANTSA 380,998 BAV 304,686 BAVPII 30,468 (b) Percent of Class: BAC 4.5% BANTSA 4.5% BAV 3.6% BAVPII .4% (c) Number of shares as to which such person has: (i) sole power to vote or direct the vote: BAC 0 BANTSA 0
- -------------------- ** By virtue of the corporate relationships between Reporting Persons as described in Item 7, BAC (the parent company) may be deemed to possess indirect beneficial ownership of shares beneficially owned directly by its subsidiaries. Similarly, higher tier BAC subsidiaries may be deemed to possess indirect beneficial ownership of shares beneficially owned directly by lower tier BAC subsidiaries. The power to vote and to dispose of shares may be deemed to be shared between entities due to their corporate relationships. Page 7 BAV 0 BAVPII 0 (ii) shared power to vote or direct the vote: BAC 380,998 BANTSA 380,998 BAV 304,686 BAVPII 30,468 (iii) sole power to dispose or direct the disposition of: BAC 0 BANTSA 0 BAV 0 BAVPII 0 (iv) shared power to dispose or direct the disposition of: BAC 304,686 BANTSA 304,686 BAV 304,686 BAVPII 30,468
Item 5 Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. Item 6 Ownership of More than Five Percent on Behalf of Another Person. Not Applicable. Item 7 Identification and Classification of the Subsidiaries Which Acquired the Security Being Reported on by the Parent Holding Company. Page 8 See Item 2. Except for BAVPII and BAVPII's individual partners, the entities described below are direct or indirect wholly-owned subsidiaries of BAC, which is a registered bank holding company. BANTSA is a bank as defined in Section 3(a)(6) of the Act. BAV and BAVPII are filing this statement under Rule 13d-1(c). BAV is a corporation and is the BAC subsidiary that held the direct investment in the issuer. BAVPII is a partnership that is related to BAV. The partners of BAVPII include: James D. Murphy, a general partner, residing in the state of California; Jess Marzak, a general partner, residing in the state of California; Anchie Kuo, a general partner, residing in the state of California; Robert Obuch, a general partner, residing in the state of California; and Rory O'Driscoll, a general partner, residing in the state of California. By virtue of these individuals being partners of BAVPII, they may each be deemed to indirectly beneficially own the ownership interest of the Issuer held by BAVPII. Similarly the partners may be deemed to share voting and/or investment power among themselves and with BAVPII in the Issuer through BAVPII. Each partner disclaims beneficial ownership of all shares of common stock owned by BAVPII. Item 8 Identification and Classification of Members of the Group. See Item 7. Item 9 Notice of Dissolution of Group. Not Applicable. Page 9 Item 10 Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. Page 10 Signature - --------- After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: February 9, 1998 BANKAMERICA CORPORATION* BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION* BANKAMERICA VENTURES* *By: /s/ VENRICE R. PALMER Venrice R. Palmer Senior Counsel of Bank of America National Trust and Savings Association and Authorized Attorney-in-Fact (signing resolutions and powers of attorney are incorporated by reference to Schedule 13G Amendment #2 relating to Anaren Microwave, Inc.) Date: February 9, 1998 BA VENTURE PARTNERS II By: /s/ Anchie Kuo ------------------------- Anchie Kuo Its: General Partner Page 11 EXHIBIT A --------- Joint Filing Agreement ---------------------- The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(f)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. Date: February 9, 1998 BANKAMERICA CORPORATION* BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION* BANKAMERICA VENTURES* *By: /s/ VENRICE R. PALMER Venrice R. Palmer Senior Counsel of Bank of America National Trust and Savings Association and Authorized Attorney-in-Fact (signing resolutions and powers of attorney are incorporated by reference to Schedule 13G Amendment #2 relating to Anaren Microwave, Inc.) Date: February 9, 1998 BA VENTURE PARTNERS II By: /s/ Anchie Kuo -------------------------- Anchie Kuo Its: General Partner Page 12 -----END PRIVACY-ENHANCED MESSAGE-----